We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
The Sports Edit (TSE) is one of the UK’s fastest-growing eCommerce retailers that sells activewear brands and products, as well as, produces content and events, centred around inspiring movement and mindfulness. It is among Europe’s foremost curators of premium activewear, partnering with 50+ leading brands. The company aims to become a major contender in the womenswear market, forecast to grow 7.7% per annum to $216 billion, by 2024. The company has >45,000 social media followers, a leading gym retail partnership, and seen its online revenues grow over 145% in the first five months of 2020 Year-Over-Year (YoY). For its timely response to customers' queries, TSE was validated by the Feefo Gold Service Award 2020 & garnered a Net Promoter Score (NPS) of 72. The company will use the investment to widen its brand & product range, hire staff for marketing and merchandising, ensure customer acquisition & retention, and launch its deal with Nike in the third quarter of 2020. 

Pitch Rated

76%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £930,307
Troubadour, a brand that specializes in creating comfortable, functional, and sustainable bags for both work and weekends. They are committed to their impact on the planet and their communities, being a certified B Corp. In 2022, Troubadour acquired the Mujjo brand, a tech accessories company, which has aided in expanding their product range and accelerating product development and customer discovery. They have experienced significant revenue growth, with a 128% increase in 2022, and continue to see substantial growth in 2023, having sold to over 30,000 customers worldwide and gaining recognition for their sustainable bags and accessories.
days to go: Expired investment: £1,771,286
ENSO is developing a new generation of cleaner, sustainable tyres and plans to disrupt the £200 billion global tyre market. It argues that conventional tyres are largely made of fossil fuels and contribute up to 28%+ of all primary ocean microplastics upon wearing down. It further points out that the increased weight and torque of electric vehicles wears tyres even faster, emitting more pollution. ENSO is addressing this crisis by developing sustainable tyres for EVs, to help reduce carbon emissions in line with the UK Government’s 'Net-Zero Strategy'. Its business is built on a direct-to-customer ‘Pay-per-Mile’ model serving EV-carmakers, fleets and private individuals directly. It claims that its latest energy-efficient tyres have achieved ‘A’ energy efficiency ratings by TÜV SÜD in Germany. The company will use the investment to deliver its first commercial tyres to EV-carmakers in 2021, and launch trials via London FreightLab, with Transport for London and DPD, with plans to expand to California by 2022.
days to go: Expired investment: £1,873,760
HUUB is a premium endurance sports apparel brand. Its products are used by Olympic gold medallists, 'IRONMAN' champions and amateur athletes. HUUB witnessed profits worth £4.8 million and an EBITDA of £420,000 in 2019. The company is a leading brand in the £60 million UK triathlon apparel & accessories market. HUBB is now targeting the US$5 billion global bike apparel market. It has built working relationships with noteworthy individuals such as former Olympian Greg Whyte and chef Gordon Ramsay. The company will use the investment to target all endurance sports through a combination of retail and distributor partnerships. It will also expand its Direct-To-Consumer (DTC) online business.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,352,941
Super U is a health food brand, creating great-tasting and nutritious superfood blends and providing a natural, innovative & convenient way of consuming superfoods, without costing the Earth. The company has 3500+ online consumers and, the social audience has risen to over 8,500 followers. Additionally, Super U has been a finalist for Start-Up Business of the Year and Health & Beauty Business of the Year 2019 - for the Great British Entrepreneur Awards. The funds will be used for growth, marketing and export strategies.
days to go: Expired investment: £160,110
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph